Koji Oba

14PUBLICATIONS
44CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Toxicology (incl. clinical toxicology)Disease surveillanceSocial epidemiologyMajor global burdens of disease
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|Dec 11, 2025
Efficacy of Adjuvant Chemotherapy for T1-2 Stage III Colorectal Cancer.

Hiromichi Maeda, Koji Oba, Kosuke Kashiwabara

|Jun 16, 2025
Sulfasalazine as a Prophylactic for Pneumocystis Pneumonia in Patients With Rheumatoid Arthritis: A Cohort Study.

Masaru Yoshimura, Nobuya Abe, Michihito Kono

|Mar 07, 2025
Correction: Glycemic Control, Renal Progression, and Use of Telemedicine Phone Consultations Among Japanese Patients With Type 2 Diabetes Mellitus During the COVID-19 Pandemic: Retrospective Cohort Study.

Akiko Sankoda, Yugo Nagae, Kayo Waki

|Nov 06, 2024
Phase II study of long-course chemoradiotherapy followed by consolidation chemotherapy as total neoadjuvant therapy in locally advanced rectal cancer in Japan: ENSEMBLE-2.

Yoshinori Kagawa, Koji Ando, Mamoru Uemura

|Jul 17, 2023
The net benefit for time-to-event outcome in oncology clinical trials with treatment switching.

Musashi Fukuda, Kentaro Sakamaki, Koji Oba

|Jun 14, 2023
Glycemic Control, Renal Progression, and Use of Telemedicine Phone Consultations Among Japanese Patients With Type 2 Diabetes Mellitus During the COVID-19 Pandemic: Retrospective Cohort Study.

Akiko Sankoda, Yugo Nagae, Kayo Waki

Pageof 3

Frequent Collaborators

2 joint publications

Masaomi Nangaku

2 joint publications

Yoshihide Asano

2 joint publications

Takemichi Fukasawa

2 joint publications

Wei Thing Sze